33 related articles for article (PubMed ID: 1356838)
1. [DNA polymorphisms].
Delpech M
Diabete Metab; 1992; 18(3):245-50. PubMed ID: 1356838
[No Abstract] [Full Text] [Related]
2. Isolation of DNA clones revealing restriction fragment length polymorphisms in the human genome.
Nishisho I; Miki T; Tateishi H; Takai S; Motomura K; Nakura J; Kumahara Y; Mori T; Honjo T
Jinrui Idengaku Zasshi; 1986 Sep; 31(3):249-58. PubMed ID: 2882041
[No Abstract] [Full Text] [Related]
3. [DNA restriction fragment length polymorphism (RFLP) of insulin and apolipoprotein A-I (apo A-I) genes in patients with diabetes mellitus coexistent with polyendocrinopathy].
Grzywa M; Buraczyńska M; Tatoń J; Matwiszyn B
Pol Tyg Lek; 1987 Dec; 42(50):1598-601. PubMed ID: 2898774
[No Abstract] [Full Text] [Related]
4. Restriction fragment-length polymorphisms of class II gene sequences in mice expressing minor structural variants of I-Ak and I-Ap.
McConnell TJ; Darby B; Wakeland EK
J Immunol; 1986 Apr; 136(8):3076-84. PubMed ID: 3007611
[TBL] [Abstract][Full Text] [Related]
5. [DNA polymorphisms and haplotypes in the apoAI-CIII gene region and coronary heart disease].
Meng X; Zhang G; Li P; Du Y
Yi Chuan Xue Bao; 1990; 17(6):411-7. PubMed ID: 1981133
[TBL] [Abstract][Full Text] [Related]
6. [Restriction fragment length polymorphisms of the antithrombin III gene--examination of the normal Japanese, abnormal AT III (Toyama) and AT III deficient families].
Oguma Y; Sakuragawa N; Hiraga K
Rinsho Byori; 1989 Apr; Spec No 81():64-74. PubMed ID: 2569046
[No Abstract] [Full Text] [Related]
7. Carrier detection in severe (type III) von Willebrand disease using two intragenic restriction fragment length polymorphisms.
Bahnak BR; Lavergne JM; Verweij CL; Rothschild C; Pannekoek H; Larrieu MJ; Meyer D
Thromb Haemost; 1988 Oct; 60(2):178-81. PubMed ID: 2905841
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and associations of apolipoprotein A-I linked DNA polymorphisms: results from a population study.
Anderson RA; Benda TJ; Wallace RB; Eliason SL; Lee J; Burns TL
Genet Epidemiol; 1986; 3(6):385-97. PubMed ID: 2879769
[TBL] [Abstract][Full Text] [Related]
9. TNFalpha promoter polymorphisms.
Fargion S; Valenti L; Dongiovanni P; Fracanzani AL
Methods Mol Med; 2004; 98():47-58. PubMed ID: 15064432
[TBL] [Abstract][Full Text] [Related]
10. DNA polymorphism analysis of hereditary multiple exostoses in horses.
Li JK; Moloney BK; Shupe JL; Gardner EJ; Leone NC; Elsner Y
Am J Vet Res; 1989 Jun; 50(6):978-83. PubMed ID: 2569854
[TBL] [Abstract][Full Text] [Related]
11. Restriction fragment length polymorphism in Felty's syndrome.
Sansom DM; Bidwell JL; Klouda PT; Maddison PJ
Dis Markers; 1986 Jun; 4(1-2):185-9. PubMed ID: 2898315
[TBL] [Abstract][Full Text] [Related]
12. Human restriction fragment length polymorphisms and cancer risk assessment.
Krontiris TG; DiMartino NA; Colb M; Mitcheson HD; Parkinson DR
J Cell Biochem; 1986; 30(4):319-29. PubMed ID: 3011817
[TBL] [Abstract][Full Text] [Related]
13. [High interindividual polymorphism in restriction fragment length and copy number of the TURI family of moderate human DNA repetitions].
Rogaev EI; Shapiro IuA
Biull Eksp Biol Med; 1987 Jan; 103(1):57-8. PubMed ID: 2879576
[TBL] [Abstract][Full Text] [Related]
14. Multiple restriction fragment length polymorphisms of the human epidermal growth factor receptor gene.
Lee JS; Ro JS; Eisbruch A; Shtalrid M; Ferrell RE; Gutterman JU; Blick M
Cancer Res; 1988 Jul; 48(14):4045-8. PubMed ID: 2898288
[TBL] [Abstract][Full Text] [Related]
15. [Polymorphism of the length of DNA restriction fragments in clinical practice].
Buraczyńska M
Pol Tyg Lek; 1987 Nov; 42(44):1369-74. PubMed ID: 2895922
[No Abstract] [Full Text] [Related]
16. [A new method for detection of DNA polymorphisms using the polymerase chain reaction].
Hayashi K
Tanpakushitsu Kakusan Koso; 1990 Dec; 35(17):3085-90. PubMed ID: 1981096
[No Abstract] [Full Text] [Related]
17. Dde I restriction fragment length polymorphism of the alpha 2-adrenoceptor gene does not correlate with blood pressure in the F2 generation obtained from crossing stroke-prone spontaneously hypertensive rats and Wistar-Kyoto rats.
Kobayashi S; Umemura S; Hirawa N; Iwamoto T; Yamaguchi S; Tamura K; Takasaki I; Ishii M
J Hypertens; 1994 Mar; 12(3):235-8. PubMed ID: 7912704
[TBL] [Abstract][Full Text] [Related]
18. The usefulness of three biallelic restriction fragment length polymorphisms versus a polymorphic dinucleotide tandem repeat polymorphism at the low-density-lipoprotein receptor gene locus for diagnosis of familial hypercholesterolemia.
Weiss N; Gudnasson V; Ostwald P; Humphries S; Schuster H; Keller C
Dis Markers; 1997 Nov; 13(3):141-51. PubMed ID: 9405927
[TBL] [Abstract][Full Text] [Related]
19. [TaqI restriction polymorphism and the HLA-B27 allele in ankylosing spondylitis].
Huetz F; Lucotte G; Kahan A; Amor B
Rev Rhum Mal Osteoartic; 1987 Mar; 54(3):175-8. PubMed ID: 2884722
[TBL] [Abstract][Full Text] [Related]
20. [Progress in the research on DNA polymorphism].
Misawa S; Fukushima H; Ikemoto S; Kajii E; Shiono H; Harada S; Mukoyama H; Saito S
Nihon Hoigaku Zasshi; 1994 Dec; 48(6):420-7. PubMed ID: 7861639
[No Abstract] [Full Text] [Related]
[Next] [New Search]
